Genomma Lab Usa Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Genomma Lab Usa

Access the complete profile.

Genomma Lab Usa Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3737 Buffalo Speedway Ste 1975 Houston, TX 77098

Note: Revenues for privately held companies are statistical evaluations.


Genomma Lab Usa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Genomma Lab Usa's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Genomma Lab Usa is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Genomma Lab Usa Annual Revenue and Growth Rate

Genomma Lab Usa	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Genomma Lab Usa's revenues are gauged from an analysis of company filings.

Genomma Lab Usa's Income Statement (based on Industry Averages)

Genomma Lab Usa P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Genomma Lab Usa is developing and marketing. Genomma Lab Usa doesn't have any recent trademark applications, indicating Genomma Lab Usa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CHERACOL PLUS pharmaceutical preparations in oral dosage form for the treatment of colds, coughs, and bronchial and pulmonary disorders	04/19/2017
CHERACOL D PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF COLDS, COUGHS, AND BRONCHIAL AND PULMONARY DISORDERS	04/19/2017
CHERACOL pharmaceutical preparations for the treatment of colds, coughs, and bronchial and pulmonary disorders	04/19/2017

See all trademarks and details in the Full Report.

Market Share of Genomma Lab Usa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Genomma Lab Usa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Genomma Lab Usa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MIDWAY IMPORTING	Houston, TX	100
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	Houston, TX	88
RALSTON WHOLESALE DRUG	Houston, TX	4
GENOMMA LAB USA	Houston, TX	2
SAN MARTIN DISTRIBUTING	Houston, TX	2
LORAND LABORATORIES	Houston, TX	1

Future Competition: Genomma Lab Usa's Fastest Growing Competitors

These companies are in the same general field as Genomma Lab Usa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)